11 / 17
PROSPER phase III trial
Hussain M, et al. PROSPER: A phase 3, randomized, double-blind, placebo-controlled study of enzalutamide in men with nonmetastatic castration-resistant prostate cancer. J Clin Oncol 36, 2018 (suppl 6S;
abstr 3) ASCO GU 2018
Phase III placebo-controlled blinded randomized international study